BTG Plc (BTG):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BTG Plc (BTG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10084
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BTG plc (BTG) develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for treating patients with severe blood clots and varicose veins; and interventional cancer products for treating patients with liver tumors and emphysema. The company develops products and acquires or in-licenses from other companies. BTG markets its products either directly or through distribution agreements. The company operates along with its subsidiaries in the US, Europe and Asia. BTG is headquartered in London, England, the UK.

BTG Plc (BTG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BTG Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BTG Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BTG Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BTG Plc, Medical Devices Deals, 2012 to YTD 2018 9
BTG Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BTG Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
BTG International Enters into Agreement with Biologics 11
BTG Enters into Co-Development Agreement with Mirada Medical 12
Licensing Agreements 13
Carrick Therapeutics Enters into Licensing Agreement with BTG 13
Wellstat Therapeutics Enters Into Licensing Agreement With BTG For Uridine Triacetate 14
Equity Offering 16
BTG to Raise USD235 Million in Private Placement of Shares 16
BTG Completes Private Placement Of Shares For US$160 Million 18
Asset Transactions 19
Eckert & Ziegler Acquires Brachytherapy Business From BTG 19
BTG Plc – Key Competitors 20
BTG Plc – Key Employees 21
BTG Plc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 25
Strategy And Business Planning 25
Oct 12, 2018: BTG licences ovarian cancer candidate to Carrick Therapeutics 25
Financial Announcements 26
May 15, 2018: BTG: Final Results For year ended 31 March 2018 26
Nov 14, 2017: BTG: Interim Results 32
May 16, 2017: BTG: Final Results 38
Corporate Communications 41
Oct 04, 2018: BTG announce Directorate change 41
Jan 23, 2018: BTG Names As Anne Thorburn Non-executive Director of the Board 42
Nov 27, 2017: BTG Announced the Appointment of Non-executive Director 43
Nov 14, 2017: BTG: Directorate change – Chief Financial Officer 44
Government and Public Interest 45
Apr 04, 2018: SIO and BTG Announce Recipients of Immuno-Oncology/Interventional Oncology Grant Program 45
Jun 07, 2017: SIO Announces First Grants in Interventional Oncology / Immuno-Oncology Research Programme 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
BTG Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BTG Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BTG Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BTG Plc, Deals By Therapy Area, 2012 to YTD 2018 8
BTG Plc, Medical Devices Deals, 2012 to YTD 2018 9
BTG Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BTG International Enters into Agreement with Biologics 11
BTG Enters into Co-Development Agreement with Mirada Medical 12
Carrick Therapeutics Enters into Licensing Agreement with BTG 13
Wellstat Therapeutics Enters Into Licensing Agreement With BTG For Uridine Triacetate 14
BTG to Raise USD235 Million in Private Placement of Shares 16
BTG Completes Private Placement Of Shares For US$160 Million 18
Eckert & Ziegler Acquires Brachytherapy Business From BTG 19
BTG Plc, Key Competitors 20
BTG Plc, Key Employees 21
BTG Plc, Subsidiaries 22

List of Figures
BTG Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BTG Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BTG Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BTG Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BTG Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BTG Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BTG Plc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[BTG Plc (BTG):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sorgenia SpA:企業の戦略的SWOT分析
    Sorgenia SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Sysmex Corp (6869):医療機器:M&Aディール及び事業提携情報
    Summary Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory inform …
  • Fronius International GmbH:企業の戦略的SWOT分析
    Fronius International GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Clydesdale Bank PLC:企業の戦略的SWOT分析
    Clydesdale Bank PLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • The Credit Mutuel-Cic Group
    The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report Summary The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Wabash Valley Power Association Inc:企業の戦略的SWOT分析
    Wabash Valley Power Association Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • DEME NV:電力:M&Aディール及び事業提携情報
    Summary DEME N.V. (DEME), a subsidiary of Compagnie d'Entreprises CFE SA is a dredging and hydraulic engineering services company. The company offers services, which include engineering solutions, installation of offshore wind farms, services to oil and gas companies, environmental activities such a …
  • iHeartMedia, Inc.:戦略・SWOT・企業財務分析
    iHeartMedia, Inc. - Strategy, SWOT and Corporate Finance Report Summary iHeartMedia, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Lophius Biosciences GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Lophius Biosciences GmbH (Lophius) is a biotechnology company that develops and markets T cell-based diagnostic systems and research tools in the areas of transplantation, infectious and autoimmune diseases. The company’s T-track immunoscan assay is a test in natural or induced immune modula …
  • The Jackson Laboratory-製薬・医療分野:企業M&A・提携分析
    Summary The Jackson Laboratory (JAX) is a nonprofit biomedical research institution that offers genomic solutions. The institution offers services in the therapeutic areas of cardiovascular, metabolic diseases, oncology, rare diseases, and neurobiology. It offers breeding and rederivation services, …
  • TUI Group:企業の戦略・SWOT・財務情報
    TUI Group - Strategy, SWOT and Corporate Finance Report Summary TUI Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Fluor Corporation (FLR)-エネルギー分野:企業M&A・提携分析
    Summary Fluor Corporation (Fluor) is a provider of engineering and construction services. The company's service portfolio includes design, engineering, procurement, fabrication, modularization, construction, commissioning and maintenance, and project management solutions. Fluor also offers other ser …
  • Royal BAM Group nv:戦略・SWOT・企業財務分析
    Royal BAM Group nv - Strategy, SWOT and Corporate Finance Report Summary Royal BAM Group nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Dillard’s Inc:戦略・SWOT・企業財務分析
    Dillard's Inc - Strategy, SWOT and Corporate Finance Report Summary Dillard's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Batu Biologics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Batu Biologics Inc (Batu Biologics) is a biotechnology based pharmaceutical company which develops and commercializes novel cell and gene therapies. Its lead product, ValloVax, a cellular anti-angiogenic cancer vaccine, is developed to induce an immune response against the tumor endothelium …
  • Roper Technologies Inc (ROP):企業の財務・戦略的SWOT分析
    Roper Technologies Inc (ROP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • University of Michigan-製薬・医療分野:企業M&A・提携分析
    Summary University of Michigan (UM) is an educational service provider that offers educational and research services. The university offers graduate, undergraduate and post-doctoral levels programs in various disciplines. It operates various graduate schools and colleges of graduate studies, archite …
  • DaVita Inc (DVA)-医療機器分野:企業M&A・提携分析
    Summary DaVita Inc (DaVita), formerly DaVita HealthCare Partners Inc., is a provider of dialysis services and integrated health care delivery and management services. The company is a provider of dialysis services in the US for patients with chronic kidney failure and end-stage renal disease (ESRD). …
  • Innoviva Inc (INVA):企業の財務・戦略的SWOT分析
    Innoviva Inc (INVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Detour Gold Corp
    Detour Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Detour Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆